Recent news on Cesamet

Valeant Pharmaceuticals Reports 2007 First Quarter Results  -  May 1, 2007
Genetic Engineering News (press release),In addition, sales of Infergen and Efudex were lower in the 2007 first quarter, while sales of Cesamet(R), Kinerase(R), Solcoseryl(TM) and Bisocard(TM) were

Valeant Pharmaceuticals Reports 2007 First Quarter Results  -  May 1, 2007
Business Wire (press release),In addition, sales of Infergen and Efudex were lower in the 2007 first quarter, while sales of Cesamet®, Kinerase®, Solcoseryl™ and Bisocard™ were higher.

Valeant Pharmaceuticals Reports Fourth Quarter and Full-Year 2006 ...  -  Feb 28, 2007
Genetic Engineering News (press release),Zelapar, Efudex, Cesamet, Kinerase, Mestinon, Diastat AcuDial, Bedoyecta, Solcoseryl and Bisocard are trademarks or registered trademarks of Valeant

Valeant: eyes indication expansion of Cesamet  -  Feb 23, 2007
Pharmaceutical Business ReviewValeant Pharmaceuticals has filed an application with the FDA to test Cesamet (nabilone) oral capsules as a treatment of cancer chemotherapy-induced

Valeant Pharmaceuticals (VRX) Files IND with FDA for Cesamet  -  Feb 22, 2007
StreetInsider.com (subscription),Cesamet, a synthetic cannabinoid, was launched by Valeant in the United States in 2006 for the treatment of nausea and vomiting associated with cancer

Valeant Pharmaceuticals Acquires Rights to Nabilone in United ...  -  Feb 16, 2007
PharmaLive.com (press release),Valeant markets nabilone in the United States and Canada under the brand name Cesamet(R). Nabilone is indicated for use in the treatment of nausea and

Stocks To Watch: BEA Systems, Cabela's, Intuit, JC Penney's, Telik  -  Feb 23, 2007
Minyanville.com,Valeant Pharmaceuticals International (VRX) said it has filed an investigational new drug application with the Food and Drug Administration for Cesamet,

Stocks to Watch, Feb. 23: Lowe's, Inuit, Clear Channel Communications  -  Feb 22, 2007
FOX NewsValeant Pharmaceuticals International (VRX) said it has filed an investigational new drug application with the Food and Drug Administration for Cesamet,

Biotech Stock Review: GPC Biotech Completes New Drug Approval  -  Feb 20, 2007
Seeking Alpha,Valeant already owns rights to the drug for Canada and the US, where it markets the drug under the name Cesamet. It is a synthetic cannabinoid,

“Smoke Two Joints and Call Me in the Morningâ€?: Health Benefits of ...  -  Feb 14, 2007
American Chronicle,While you can’t buy a pack of joints at your local pharmacy, the FDA has approved two drugs, Marinol and Cesamet, which contain active ingredients that are

NCCN Updates Antiemesis Guidelines  -  Jan 8, 2007
PharmaLive.com (press release),Nabilone (Cesamet, Valeant) is now recommended for breakthrough treatment. The guidelines table describing the emetogenic potential of different

Valeant Drug's Effectiveness Highlighted in Study  -  Dec 18, 2006
Orange County Business Journal,New research released shows that Valeant Pharmaceuticals International’s Cesamet, a synthetic version of marijuana’s active ingredient, helps relieve

Synthetic marijuana helps cancer patients - study  -  Dec 16, 2006
Reuters South Africa,The 139-patient study involved a drug called nabilone, sold under the brand name Cesamet by Valeant Pharmaceuticals International.

Downtown Drug Bust  -  Dec 12, 2006
Guelph Tribune,When the vehicle was searched, police found 35 grams of marijuana, 17 grams of cocaine, 35 ecstasy tablets and 90 Cesamet tablets, a police news release

Vehicle search nets drugs  -  Dec 11, 2006
Guelph Mercury (subscription),In a vehicle search, an officer found 35 grams of marijuana, 23 grams of cocaine, 35 ecstasy tablets, 90 Cesamet pills, $2710 in cash, two cellphones and

Police report December 11  -  Dec 11, 2006
Fountain Pen,They found 35 grams of marijuana, 17 grams of cocaine, 35 ecstasy tablets and 90 Cesamet tablets. Murray Jones, 27 years, of Guelph was to be in court on 11

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional